Therapeutic Prescribing Data Collection - FAQ

Posted On: March 5, 2026

  1. Should I include numbers for IVIT compounding and injections for this data collection?

No, this data submission is for prescribing and administrations related to the Therapeutic Prescribing Standard only.

For compounding, this includes those drugs listed in Table 5 being compounded for non-IVIT administration, as well as any substances being mixed for the purposes of administering an intramuscular injection (see Question 2 below).

For injections, you should include only those substances listed in Table 2 administered by non-intravenous injection (intramuscularly or subcutaneously) and report those under “Administration of substance by Injection to patients” on the Data Reporting Form.

  1. If I mix substances together to administer an intramuscular injection, do I count this as compounding?

As stated above, even though the substances you are combining to administer an intramuscular injection may not appear on Table 5, because you are combining substances for the purposes of injection, you should include this as compounding and apply the Standard of Practice for Compounding to the process.

  1. When reporting the number of drugs prescribed to patients, should I be reporting the unique number of drugs I have prescribed from those listed in Table 3, or the total number of prescriptions I have given to patients?

You should be reporting the total number of prescriptions you have provided to patients for the drugs listed in Table 3. This means for example, that if you prescribed oral vitamin D at a dose of over 2500 IU per day 30 times last year, you should count 30 towards your total number of prescriptions.

When you perform the controlled act of prescribing, you should be doing two things: providing a prescription to the patient and making an entry into the patient record. Every time you do those two things, you should note this as a prescription to be counted.

  1. Should I count the number of refills provided on a prescription toward the total number of prescriptions?

No, prescription refills do not count towards the total number of prescriptions. When you provide a patient with a prescription that allows for X number of refills, that is one prescription. If a patient returns to you after the refills are exhausted and you provide another prescription for the same or a different drug, this new prescription would count towards your total.

For example, if you prescribe bioidentical estrogen to a patient with 3 refills, this counts as one prescription. If the patient returns after using their refills and you issue an identical prescription for the same drug with 3 refills, this also counts as one prescription.

  1. I noticed that in Tables 3-6, vitamin D refers to the dose on the label when determining whether or not it is a drug. How should I interpret this?

Vitamin D, like many of the vitamins listed on Tables 3-6, is dosage dependent. These vitamins become a drug only at certain levels. If you instruct a patient to take a vitamin at a level that is at or below the level in the limitation, it is not a drug that has prescribed, dispensed, compounded or sold. If you instruct a patient to take a vitamin above the level in the limitation, it is a drug and must be counted as prescribed, dispensed, compounded or sold.

For example, if you prescribe, dispense, compound or sell oral vitamin D at a dose of more than 2500 IU per day to a patient, you should count this towards your total numbers for the data submission under the respective controlled act. (As an aside, if you inject vitamin D at any level, it is always considered a substance that has been injected and should be counted as an administration by injection.)

The Standard of Practice for Dispensing provides information on what must be included on a label when a drug is dispensed, including “Directions for the proper use of the drug or substance including dose, frequency, route of administration and any special instructions. This information may be included in a label affixed to the product, or where space is limited, information may be provided on an accompanying sheet.” Thus, if you have prescribed oral vitamin D at a dose of more than 2500 IU per day, you will be providing this label information to the patient along with the drug.

  1. If I direct a patient to administer an inhalation treatment with a substance found in Table 1 at home or to administer a self-injection with a substance found in Table 2 at home, should I count these towards my total numbers for the submission?

In these scenarios, you are delegating the controlled act to the patient to perform at home. While this may be considered for inclusion in a future year, this is not a situation the College has considered to this point and therefore, these administrations should not be included in your data submission.

  1. Do you have any advice on how I can track my data for future Therapeutic Prescribing submissions? I’d like to stay on top of it this year!

Yes, the College has developed a Therapeutic Data Collection Support System that allows you to keep track of your data on an ongoing basis throughout the year for tabulation purposes. You can set the frequency with which you would like to receive reminders to gather and record your data. You can find more information here or in the January 2026 edition of iNformeD.

Please note that you will still need to complete the required submission form at the end of the year to formally provide your data to the College.

  1. I have enrolled in the Therapeutic Data Collection Support System part way through the year. How can I go back and add data from earlier?

The link to the form you were provided with when you enrolled can be used to enter data for any period, including those in the past. Entering data does not impact the reminders that you receive. You also have the ability to edit your data as needed throughout the year.

At the end of the year when it is time to report your data, you will be able to review everything you have tracked and make any corrections before you formally submit.

Back to News & Announcements